Navigation Links
CONCERTA(R) (methylphenidate HCI) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS
Date:9/9/2009

ers are believed to play a role in behaviors like attention and movement. Much like height or eye color, ADHD can be inherited. Studies suggest that 76 percent of ADHD is linked to family genetics. So the condition is more common among people who have a close relative with ADHD. Adults with ADHD have a 50 percent chance of passing it on to their children.

About CONCERTA((R))

CONCERTA((R)) is a prescription product approved for the treatment of attention deficit hyperactivity disorder (ADHD) as part of a total treatment program that may include counseling or other therapies.

IMPORTANT SAFETY INFORMATION

Talk to your healthcare professional for a proper diagnosis and treatment of ADHD. Only a healthcare professional can decide whether medication is right for you or your child.

CONCERTA((R)) should not be taken by patients who have: allergies to methylphenidate or other ingredients in CONCERTA((R)); significant anxiety, tension, or agitation; glaucoma; tics, Tourette's syndrome, or family history of Tourette's syndrome; current or past use of monoamine oxidase inhibitor (MAOI); esophagus, stomach, or intestinal narrowing. Children under 6 years of age should not take CONCERTA((R)).

Abuse of methylphenidate may lead to dependence. Tell your healthcare professional if you or your child has had problems with alcohol or drugs; has had any heart problems, heart defects, high blood pressure, or a family history of these problems; has had depression, abnormal thoughts or visions, bipolar disorder, or seizure. Contact your healthcare professional immediately if you or your child: develops abnormal thinking or hallucinations, abnormal or extreme moods and/or excessive activity; or if aggressive behavior or hostility develops or worsens while taking CONCERTA((R)). Your child's healthcare professional should check height and weight
'/>"/>

SOURCE McNeil Pediatrics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. District Court Decision Received in CONCERTA(R) Patent Case
2. Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
3. Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
4. ICC Launches New Elpac Brand Convection Cooled 100-Watt Open Frame Power Supply
5. Bounty Parenting Club Launches View on Demand How to Breastfeed Video
6. Founder of Curidium Launches Elixior, an Advisory Company Focused on the Development and Growth of Innovative Personalized Medicine Businesses
7. Fairfield, New Jersey Cosmetic Dentistry Practice Launches State-of-the-art New Website
8. National Alliance on Mental Illness (NAMI Michigan) Launches TV Awareness Campaign
9. PRC Launches New Web Resource for Teaching Language to Children & Adults with Speech Disabilities
10. Rochester Medical Launches StrataSI(TM) & StrataNF(TM) Next Generation Foley Catheters
11. RBC Life Sciences Launches New Initiatives Aimed at Building Its Network Marketing Business Across North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... Move over shave cream. Roll ... and barbershops are scrambling to meet it. , Reports published this year (Mintel data) ... haircare. But the data also reflects that men are getting more done at barbershops ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... (ACLM), the nation’s medical professional association for physicians and allied health professionals ... the Lifestyle Medicine Foundation, announced today the establishment of the Lifestyle Medicine ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... in and around Grand Prairie, is teaming up with the Tarrant County chapter ... area. , Meals on Wheels is the oldest and largest national organization that ...
(Date:8/31/2015)... ... August 31, 2015 , ... Chicago-based company The Mood ... to raise money and awareness for breast and ovarian health. During September ... incandescent Mood-lite sold to Bright Pink® to encourage households, dorms, and offices around ...
(Date:8/31/2015)... Los Angeles, ACA (PRWEB) , ... August 31, 2015 , ... ... filling a growing niche in the digital healthcare industry. , Consumer driven health ... the field: one in an advisory and strategic role to the company, and another ...
Breaking Medicine News(10 mins):Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 2Health News:Nominations Sought for Awards Recognizing Exemplary Contribution to the Field of Lifestyle Medicine 3Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 3Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 2Health News:Mood-lites® is proud to launch “Brighten Our World" Campaign to Raise Money and Awareness for Breast and Ovarian Health Across America in Partnership with Bright Pink® 3Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3
... in the February issue of Radiology, a novel type ... in identifying blockages// in the arteries that carry blood ... provided highly accurate information about the supra-aortic arteries," said ... the David Geffen School of Medicine at UCLA in ...
... increase of HIV cases in Australia has prompted the government ... disease//. Gay sex has been found out to be main ... island continent. ,According to a study, there is ... a disturbing scenario. Health ministry is planning to spend $10 ...
... been granted ?25,000 for helping blind and partially sighted people ... National Institute for the Blind (RNIB) received a ?25,000 donation// ... launching the charity's Positive Steps programme, which provides motivational training ... will be conducted for those who are over 17 years ...
... leading public health experts said that NHS should consider ... charges//. Patients should contribute towards the cost of ... Tim Crayford, president of the Association of Directors of ... to be controlled and people should help pay for ...
... improve their smile but there is no guarantee of happiness ... results were published in the British Journal of Health Psychology. ... study looked at the impact of braces on more than ... little positive impact on their psychological health later in life. ...
... patients conclude that placing stents in carotid arteries to prevent ... at Sacred Heart Medical Center in Spokane, Washington by lead ... 37 stroke patients on whom the procedure was performed. ... reported an improvement in reasoning, memory and judgment. ...
Cached Medicine News:Health News:MR Angiography Detects Blocked Arteries Accurately 2
(Date:8/28/2015)... , Aug. 28, 2015  With the heroin ... reaching deadlier heights, Jacksonville -based Lakeview ... Hemphill is helping to explain why fentanyl is ... approximately 40 to 50 times more potent than pharmaceutical ... users as heroin, the risk of death skyrockets. ...
(Date:8/28/2015)... SAN FRANCISCO, Calif. , Aug. 28, 2015 /PRNewswire/ ... for the treatment of cancer, today announced the filing ... U.S. Securities and Exchange Commission (SEC) relating to a ... number of shares to be offered and the price ... CytomX intends to list its common stock under the ...
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Pranoprofen Market, 2010-2019" ... discovered by Welfide (Mitsubishi Tanabe Pharma Corporation formerly ... inflammatory drug, pranoprofen was later developed into eye ... trade name of pranopulin for the treatment of ...
Breaking Medicine Technology:Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Pranoprofen Market, 2010-2019 2
... on Benefit of Intensive Blood Sugar Control Are, Not Statistically Significant but ... ... Events, SAN FRANCISCO, June 8 Findings from ... study in high-risk diabetes patients were,released today at the 68th Scientific Sessions ...
... Therapy in Q1 2008, SAN FRANCISCO, June 7 ... Lilly and Company (NYSE: LLY ) today announced,additional ... diabetes who were,unable to achieve glycemic control through diet ... BYETTA(R) (exenatide),injection taken twice daily or placebo. Study findings ...
Cached Medicine Technology:Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R) 2Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R) 3Large, Long-Term Veterans Affairs Diabetes Trial (VADT) Reveals Important Cardiovascular Safety News on AVANDIA(R) 4Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 2Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 3Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 4Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 5Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 6Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 7
... Pediatric Flowmeters, ,Options: , ... S to model number. Example: ... add suffix C to model ... Double Flowmeters with Power Take-Off, ...
FM Style Neonatal Flowmeters (Brass Body)...
... Adult Flowmeters, ,Options: , ... S to model number. Example: ... add suffix C to model ... Double Flowmeters with Power Take-Off, ...
... designed specifically for detection of recent-onset neovascular ... perimeter maps and quantifies visual field defects ... AMD to the wet stage of the ... compensate for small visual field defects, the ...
Medicine Products: